Target intelligence / Profile preview

Eurotium cristatum (E. cristatum)

Target
E. cristatum
Molecular classification
Other (probiotic fungus; not a receptor, enzyme, transporter, or classical therapeutic target)
01

Overview

Eurotium cristatum is a probiotic fungus best known as the dominant strain involved in the fermentation of Fu (Fuzhuan) brick tea, where it is commonly referred to as the "golden flower" fungus[1][3][5][6]. It produces a wide array of extracellular enzymes and metabolic products, such as polysaccharides and secondary metabolites, which have been shown to modulate gut microbiota, inhibit pathogenic microorganisms, regulate immune responses, provide anti-inflammatory effects, and aid in weight management and fat reduction[1][5][6][7]. Research has demonstrated beneficial effects in animal models of obesity and ulcerative colitis, primarily through modulation of the gut microbial community and enhancement of beneficial short-chain fatty acid production[1][3]. E. cristatum is not a molecular drug target (such as a receptor, enzyme, or transporter), but rather a live microbial strain considered for its health-promoting, probiotic properties in functional food development and disease risk reduction[6].\n\nNote on target validity:\nThis entry does not describe a classical drug target (e.g., molecular receptor, enzyme, or transporter) but rather a microbial strain used as a probiotic, making "Probiotic effect via Eurotium cristatum" a mischaracterization for molecular targeting; it is not a therapeutic target in the pharmacological sense[5][6].

Other names
Aspergillus chevalieri (historical synonym)Aspergillus cristatusgolden flower (common name in tea fermentation)
02

Mechanism of action

Not drug-targetable; exerts effects through modulation of microbiota and production of metabolic products (e.g., polysaccharides, secondary metabolites)\nSecretion of enzymes and metabolites with antimicrobial, anti-inflammatory, and immune-modulating effects

03

Biological functions

Modulation of gut microbiotaProduction of extracellular enzymesAnti-inflammatory activityAntimicrobial activityImmune regulationFat metabolism modulationAntitumor activity
04

Disease associations

Inflammation (e.g., ulcerative colitis)ObesityInfection (through antimicrobial activity)Other (potential in cancer prevention and therapy)
05

Safety considerations

No major safety concerns reported in current literature; human studies limited—potential allergenicity or microbial contamination should be considered with probiotic use

Beyond the preview

Go deeper on Eurotium cristatum (E. cristatum).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurotium cristatum (E. cristatum).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call